BI-754091
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for BI-754091, covering 2024-07-08 to 2026-01-27. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Find and Investigate a Safe Dose of a New Substance (BI 754091) for Patients With Solid Tumours [Phase 1]